Monica E Calkins
Overview
Explore the profile of Monica E Calkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
8363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marsteller J, Goldberg R, Boumaiz Y, Jumper M, Taylor J, Saravana A, et al.
Schizophr Res
. 2025 Mar;
277:74-85.
PMID: 40023005
The Connection Learning Healthcare System (CLHS) represents a network of academic institutions, state behavioral health systems, and early psychosis specialty care programs in Pennsylvania and Maryland working together to provide...
2.
Pecsok M, Robinson H, Atkins A, Calkins M, Elliott M, Mordy A, et al.
Front Aging Neurosci
. 2025 Feb;
16:1535158.
PMID: 39926356
Introduction: Hippocampal glutamate (Glu) dysfunction is a pertinent indicator of neurodegeneration, yet mapping typical age-related changes in Glu has been challenging. Here, we use a 7T MRI approach, Glutamate Chemical...
3.
Calkins M, Ered A, Moore T, White L, Taylor J, Moxam A, et al.
Schizophr Bull
. 2025 Jan;
PMID: 39792431
Background And Hypothesis: Improvements in screening tools for early subthreshold psychosis symptoms are needed to facilitate early identification and intervention efforts, especially given the challenges of rapidly differentiating age-appropriate experiences...
4.
Souders M, McDonald-McGinn D, Ruparel K, Moore T, Tang S, Calkins M, et al.
Psychiatry Res
. 2024 Dec;
344():116336.
PMID: 39731884
The 22q11.2 Deletion Syndrome (22q11.2DS) is a multisystem genetic disorder with prominent sleep disturbances, neuropsychiatric conditions and neurocognitive challenges. Poor sleep can impact cognitive development, psychopathology and daily functioning. An...
5.
Cooper E, Schindler M, Bar-Or A, Brandstadter R, Calkins M, Gur R, et al.
medRxiv
. 2024 Oct;
PMID: 39464257
Multiple sclerosis (MS) is an immune-mediated neurological disorder that affects one million people in the United States. Up to 50% of people with MS experience depression, yet the mechanisms of...
6.
Phalen P, Jones N, Davis B, Sarpal D, Dickerson F, Vatza C, et al.
Schizophr Res
. 2024 Sep;
274:150-157.
PMID: 39298811
Background: People experiencing their first episode of psychosis have high risk of suicide, and programs specializing in early psychosis have not always achieved reduced risk. The present study analyzes patterns...
7.
Phalen P, Smith W, Jones N, Reznik S, Marti C, Cosgrove J, et al.
Schizophr Bull
. 2024 Jul;
PMID: 39030696
Background: Discharge from early psychosis intervention is a critical stage of treatment that may occur for a variety of reasons. This study characterizes reasons for discharge among participants in early...
8.
Pagdon S, Shahriar S, Murphy S, Babusci C, Flores A, Rivens A, et al.
Psychiatr Serv
. 2024 Jul;
75(11):1157-1160.
PMID: 38957052
Attention to inclusivity and equity in health research and clinical practice has grown in recent years; however, coordinated specialty care (CSC) for early psychosis lags in efforts to improve equity...
9.
Bennett M, Calkins M, Dickerson F, Kreyenbuhl J, Medoff D
Schizophr Res
. 2024 Jun;
270:235-236.
PMID: 38936115
No abstract available.
10.
Roalf D, McDonald-McGinn D, Jee J, Krall M, Crowley T, Moberg P, et al.
J Neurodev Disord
. 2024 Jun;
16(1):35.
PMID: 38918700
Background: Minor physical anomalies (MPAs) are congenital morphological abnormalities linked to disruptions of fetal development. MPAs are common in 22q11.2 deletion syndrome (22q11DS) and psychosis spectrum disorders (PS) and likely...